glp-1 tirzepatide side effects vs Semaglutide: What You Need to Know Semaglutide vs tirzepatide side effects:

Many individuals also report fewer cravings for certain foods while using it

Long trials and reviews have not confirmed that link, and the early fears have largely been dispelled (Jalleh 2026)

If the answer is yes, the medication may not be creating new anxiety

Recent Mergers & Acquisitions (M & A) 2025-2026: Mar 2026: BioMarin Pharmaceutical agreed to acquire rare disease biotech Amicus Therapeutics for $4.8B, strengthening metabolic & rare disease franchise overlap with diabetes-associated disorders Mar 2026: Sanofi entered $2.2B acquisition deal for Dynavax Technologies to expand vaccine and immunometabolic pipeline supporting diabetes-comorbidity therapeutics Jan 2026: Eli Lilly and Company announced acquisition of Ventyx Biosciences for $1.2B, expanding cardiometabolic and diabetes-related pipeline into immunology-linked therapies 2026 (closed/announced): Merck & Co

An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations

Genetics and other individual factors are likely involved